Company intelligence / Profile preview

DCI Partners

Ownership: Private
Development stage: Other

Overview

DCI Partners is Japan’s largest sector-focused life science venture capital firm. It invests in biotechnology and drug discovery startups primarily in Japan and Taiwan, often leading or creating new startup entities around promising drug candidates from universities, research institutes, pharma companies, and early-stage ventures. The firm provides hands-on support leveraging expertise in clinical development, IP strategy, business development, and maintains strong networks across academia and industry.

Industry: Investors

Partnerships

Notable partnerships with academic institutions and biopharma through investments but no specific major pharma partnerships listed directly for the VC itself

Beyond the preview

Go deeper on DCI Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DCI Partners.

Explore the full profile